Records containing: Leptomeningeal Metastasis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-06-11Phase II Study of Osimertinib With Bevacizumab for Leptomeningeal Metastasis From EGFR-mutation Non-Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2020-05-27Efficacy and Safety of Durvalumab Combined With Intrathecal Chemotherapy in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis
-
CLINICAL_TRIALS study record update · 2020-05-27Efficacy and Safety of Recombinant Human Endostatin in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis
-
CLINICAL_TRIALS study record update · 2019-12-26Intrathecal-pemetrexed Combined With Concurrent Involved-field Radiotherapy for Leptomeningeal Metastasis From Solid Tumor: a Phase I/II Clinical Trial
-
CLINICAL_TRIALS study record update · 2019-11-26Tomotherapy for Leptomeningeal Metastases: a Single Arm, Single Center, Phase II Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-11-04A Randomized Phase II Trial of Osimertinib Alone or in Combination With Bevacizumab for EGFR- Mutant Non-small Cell Lung Cancer With Leptomeningeal Metastasis
-
CLINICAL_TRIALS study record update · 2019-08-01Involved-field Radiotherapy Combined With Concurrent Intrathecal-MTX Versus Intrathecal-Ara-C for Leptomeningeal Metastases From Solid Tumor: A Randomized Phase II Clinical Trial
-
CLINICAL_TRIALS study record update · 2016-06-17ClinicalTrials.gov study NCT02803619
-
CLINICAL_TRIALS study record update · 2013-10-16A Phase II Study of Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal Metastasis